| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |